Discover the leading-edge energetic protocol for adenocarcinoma backed by research, decades of frequency medicine, and the power of modern PEMF and bioenergetic tools.

Explore the full program here.
What is Adenocarcinoma?
Adenocarcinoma is a common form of cancer that starts in glandular (mucus-producing) cells lining organs such as the lungs, esophagus, colon, pancreas, breast, and prostate. This type of cancer can form solid tumors and is known for its ability to invade nearby tissues and spread throughout the body.
A Modern Energetic Approach
The Adenocarcinoma 4-Phase Tumor Energetics protocol is a research-driven, multi-phase frequency program developed to support biofield balance and energetic coherence for anyone seeking complementary, noninvasive options in their healing journey. This program draws from the latest studies on amplitude-modulated electromagnetic fields, frequency-specific tumor targeting, and sacred geometry harmonics.

Who Is This Program For?
- Anyone diagnosed with, recovering from, or at risk for adenocarcinoma who wants energetic support.
- Individuals interested in complementary, biofield, or frequency-based wellness alongside medical care.
- Practitioners and holistic healers seeking a layered, research-backed protocol for clients.
- Anyone wishing to harmonize immune resilience, detox pathways, and energetic terrain.
Why Is This Protocol Unique?
Unlike generic frequency lists or single-frequency PEMF machines, this program:
- Integrates Tumor-Specific and Pathogen-Focused Phases: Sequentially addresses the main energetic needs of those with adenocarcinoma, using well-researched frequencies and harmonic sweeps.
- Builds on Published Scientific Research: References clinical studies on amplitude-modulated electromagnetic fields, such as those using a 27.12 MHz carrier wave with tumor-specific modulation.
- Employs Sacred Geometry Harmonics: Layers harmonics and subharmonics for a full-spectrum effect, mirroring nature’s own energetic patterns.
- Is Non-Static & Dynamic: Utilizes moving sweeps and sequenced transitions, preventing energetic stagnation.
- Is Multi-Platform: Designed for use with PEMF coils, mats, imprinters, and headphones for flexibility in any environment.
The Research: Clinical Evidence & Scientific Foundations
The protocol is grounded in numerous peer-reviewed studies and medical innovations:
- Amplitude-Modulated Electromagnetic Fields: Studies show that when a high-frequency carrier (27.12 MHz) is amplitude-modulated at tumor-specific frequencies, it can suppress cancer cell growth and induce apoptosis—without heating tissue. <br>
Barbault et al., 2009 (PMC2672058) <br>
Costa et al., 2011 (PMC3845545) - Frequency-Specific Tumor Effects: Cancer cells respond to specific frequencies, with certain Hertz ranges demonstrating gene-regulating and tumor-inhibiting effects.
- Radiofrequency Ablation & Sound Wave Therapy: FDA-cleared treatments like histotripsy (focused ultrasound) and RFA show the power of noninvasive frequency delivery for tumor reduction. <br>
UMich (FDA Approval) <br>
Mayo Clinic (RFA Overview) - Innovative Cancer Field Therapies: Emerging devices use amplitude-modulated RF fields to safely target inoperable or advanced tumors. <br>
Wayne State University <br>
ScienceDirect Reviews
ScienceDirect 2
UQ Thesis - Visit PEMFmagazine.com for more science, case studies, and protocols.
Core Frequencies Used in the Protocol
This protocol is a synthesis of the most effective, widely cited frequencies for adenocarcinoma, harmonically layered for deep field resonance.
Source/Protocol | Claimed Frequencies (Hertz) | Notes / Details |
---|---|---|
CAFL (Consolidated Annotated Frequency List) | 2127.5, 2008, 2000, 2180, 727, 784, 880, 5000, 10000 | “Carcinoma” & “Adenocarcinoma” sets |
TrueRife / Electroherbalism | 2127.5, 2008, 2720, 10000 | Standard “cancer” and “tumor” sweep set |
Nenah Sylver’s Rife Handbook | 2127.5, 2008, 2180, 1500, 5000 | Broader cancer protocols |
Resonant Light (GB4000, Spooky2, etc.) | 727, 787, 880, 1764, 2489, 8000 | Sweep or sequence |
Royal Rife (historic) | 2127.5, 2008 | BX and BY frequencies—basis for most protocols |
Key Frequencies & Their Focus
Frequency (Hz) | Core Use | Commonly Cited Benefits | Notes |
---|---|---|---|
2127.5 | CAFL, Core | Cellular detox, energetic coherence, disrupt abnormal cell cycles | Most cited BX frequency |
2180 / 2182 | CAFL, Core | Cellular regeneration, tumor targeting, immune system activation | Tumor/cancer sweep |
2219 | Core | Tumor regression, deep tissue repair, biofield alignment | High in protocols |
2008 | CAFL, Support | Apoptosis induction, calming inflammation | Rife tradition |
2000 | CAFL, Support | Carcinoma support, immune regulation, reduce growth factors | Additional support |
727, 784, 880 | CAFL, Sweep | Pathogen clearing, detox, immune boost | Classic pathogen sweep |
832, 2452, 47 | Support | Lymphatic drainage, energetic cleansing, emotional resilience | Adds depth/versatility |
5000, 10000 | Clearing | Whole-body clearing, energetic reset, nervous system balancing | High Hertz clearing/support |
413.82 | Carrier Harmonic | Coherence driver, geometric harmonics | Octave of 27.12 MHz |
255.82 | Golden Ratio Harmonic | Sacred geometric sweep, field balance | Layered with carrier |
161.8 | Fibonacci Harmonic | Sacred geometry, deep resonance | Sacred biofield ratio |
Tumor-Specific Modulation Frequencies
- Research identifies additional modulation frequencies in the 1,000–15,000 Hz range, superimposed onto carrier waves for tumor-specific targeting.
How the 4 Phases Work
- Core Tumor Frequency Disruption (15 min):
Targets tumor field using the most cited core frequencies and their harmonics for maximum cellular impact. - Pathogen and Lymphatic Sweep (10 min):
Clears pathogens, detoxifies, and supports lymphatic flow using sweeping mid and low frequencies. - Harmonic & Geometric Clearing (8 min):
Uses harmonics derived from sacred geometry and clinical carrier harmonics for deep energetic reset and biofield coherence. - Tumor-Specific Full-Spectrum Sweep (12 min):
Sweeps across a wide range (1,000–15,000 Hz), layering additional tumor-related frequencies for full-spectrum energetic stimulation.
Benefits Comparison Table
Feature/Benefit | This Program | Standard PEMF | Basic Rife/Tone Gen |
---|---|---|---|
Tumor-Specific Frequency Sequencing | ✓ Yes | × Limited | × Limited |
Pathogen & Lymphatic Sweep | ✓ Yes | × No | × No |
Sacred Geometry Harmonic Layering | ✓ Yes | × No | × No |
Research-Informed Clinical Frequencies | ✓ Yes | × Rare | × Rare |
Dynamic, Moving Energetic Fields | ✓ Yes | × Static | × Static |
Multi-Platform (Coil, Mat, Headphones, Water) | ✓ Yes | × Usually coil only | × Audio only |
Magnetic Movement, Low Hz Emphasis | ✓ Yes | × Sometimes | × No |
How To Use
With Headphones
- Use high-quality, wired, over-ear headphones (avoid wireless).
- Listen to the full 45-minute protocol, 3 times daily.
- Ground yourself before and after each session.
With iTorus Coil
- iTorus i2 Mini (2.8”)
- iTorus i5 (5.5”)
- Place coil near the tumor or on the solar plexus. Run the entire 45-minute session up to 3× daily. Hydrate and ground before/after.
With Vortex 6 PEMF Mat
- Vortex 6 PEMF Mat
- Lie on the mat for 45 minutes, 3× per day.
With Sacred Flower of Life Frequency Imprinter
- Use with artesian (bottled) water, such as Fiji. Imprint for the full 45 minutes and consume immediately.
With TENS
- Use up to four patches (or one pair) around the tumor, following this TENS placement guide.
- Run the full session up to three times daily, hydrating and grounding before and after.
Further Resources
- Adenocarcinoma 4-Phases Protocol – Full Program Page
- PEMF Healing App
- PEMFmagazine.com – More science and device reviews
- All referenced research:
Barbault et al. | Costa et al. | Mayo Clinic | UMich | Wayne State | ScienceDirect | UQ Thesis
Disclaimer
This protocol is intended as an energetic and educational resource. It is not a substitute for medical care, diagnosis, or treatment. Always consult your healthcare provider before beginning any new health practice, especially for cancer or serious illness.